Search hospitals > Louisiana > Baton Rouge
Mary Bird Perkins Cancer Center
Claim this profileBaton Rouge, Louisiana 70809
Global Leader in Thyroid Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
263 reported clinical trials
6 medical researchers
Summary
Mary Bird Perkins Cancer Center is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Mary Bird Perkins Cancer Center is involved with conducting 263 clinical trials across 288 conditions. There are 6 research doctors associated with this hospital, such as David S. Hanson, Victor T. Lin, Augusto C. Ochoa, and Patricia Braly, MD.Area of expertise
1Thyroid Cancer
Global LeaderStage IV
Stage III
Stage II
2Breast Cancer
Global LeaderHER2 negative
ER positive
Stage IV
Top PIs
David S. HansonMary Bird Perkins Cancer Center5 years of reported clinical research
Expert in Thyroid Cancer
Expert in Lung Cancer
38 reported clinical trials
82 drugs studied
Victor T. LinMary Bird Perkins Cancer Center1 year of reported clinical research
Expert in Thyroid Cancer
Expert in Lung Cancer
41 reported clinical trials
97 drugs studied
Augusto C. OchoaLouisiana State University Health Science Center8 years of reported clinical research
Studies Breast Cancer
Studies Thyroid Cancer
19 reported clinical trials
75 drugs studied
Patricia Braly, MDWomen's Cancer Care3 years of reported clinical research
Studies Ovarian Cancer
Studies Fallopian Tube Cancer
10 reported clinical trials
23 drugs studied
Clinical Trials running at Mary Bird Perkins Cancer Center
Lung Cancer
Bladder Cancer
Prostate Cancer
Non-Small Cell Lung Cancer
Thyroid Cancer
Breast Cancer
Pancreatic Cancer
Uterine Tumors
Lymphoma
Pancreatic Carcinoma
Cancer Vaccine
for Lung Cancer
Multicenter, randomized (2:1), open-label phase 3 study in HLA-A2 positive patients with squamous and non-squamous metastatic NSCLC with ICI secondary resistance. Patients will be randomized into 2 arms (randomization 2:1): experimental Arm A with OSE2101 monotherapy or control Arm B SoC with docetaxel monotherapy. Stratification factors will be histology (squamous versus non squamous) and ECOG Performance Status (0 versus 1).
Recruiting2 awards Phase 32 criteria
Crizotinib
for Non-Small Cell Lung Cancer
This randomized phase III trial studies how well crizotinib works in treating patients with stage IB-IIIA non-small cell lung cancer that has been removed by surgery and has a mutation in a protein called anaplastic lymphoma kinase (ALK). Mutations, or changes, in ALK can make it very active and important for tumor cell growth and progression. Crizotinib may stop the growth of tumor cells by blocking the ALK protein from working. Crizotinib may be an effective treatment for patients with non-small cell lung cancer and an ALK fusion mutation.
Recruiting2 awards Phase 328 criteria
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Mary Bird Perkins Cancer Center?
Mary Bird Perkins Cancer Center is a medical facility located in Baton Rouge, Louisiana. This center is recognized for care of Thyroid Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer and other specialties. Mary Bird Perkins Cancer Center is involved with conducting 263 clinical trials across 288 conditions. There are 6 research doctors associated with this hospital, such as David S. Hanson, Victor T. Lin, Augusto C. Ochoa, and Patricia Braly, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.